Company news

Novacyt Sas (EURONEXT:ALNOV) news

Every Novacyt Sas press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Novacyt Sas stock analysis →

Press releases & updates

REG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR

July 1, 2026

REG - Novacyt S.A. - Result of AGM

June 30, 2026

REG - Novacyt S.A. - Publication of Annual Report

June 11, 2026

ALNOV: Revenue up, EBITDA loss narrowed, and cash supports growth and acquisitions

April 30, 2026

ALNOV: Acquisition delivers immediate profitability, expanded portfolio, and direct market access

April 8, 2026

Novacyt agrees to acquire Southern Cross Diagnostics

February 23, 2026

REG - Novacyt S.A. - NIPT Tender Award

January 27, 2026

ALNOV: Revenue up 4% to £20.0m in 2025, with strong cash and growth in Instrumentation and APAC

January 21, 2026

Novacyt SA Expects Slight Increase In H2 2025 Revenues

October 22, 2025

ALNOV: EBITDA loss narrowed, cash remains strong, and reproductive health drives growth

September 30, 2025

REG - Novacyt S.A. - Notice of Results

September 18, 2025

REG - Novacyt S.A. - Appointment of Joint Corporate Broker

September 15, 2025

REG - Novacyt S.A. - Resolution re. Lab 21 HSE Prosecution

September 12, 2025

REG - Novacyt S.A. - Liquidity Agreement Monthly Update & TVR

August 1, 2025

Novacyt SA Expects H1 2025 Revenue To Be About £9.8 Mln

July 29, 2025

ALNOV: Liquidity contract activity increased share holdings to 104,002 and set a €5.00 buyback cap

July 28, 2025

REG - Novacyt S.A. - Launch of LightBench® Discover

July 15, 2025

Novacyt : Annual Report and Accounts for the year ended 2024

June 16, 2025

REG - Novacyt S.A. - Liquidity Agreement and Total Voting Rights

June 2, 2025

REG - Novacyt S.A. - AGM Voting

May 28, 2025

REG - Novacyt S.A. - Notice of AGM

May 12, 2025

Novacyt : 2024 Full Year Results Presentation (EN)

May 1, 2025

ALNOV: GBP 8 million in savings and 26% growth in reproductive healthcare drive strong outlook

April 30, 2025

ALNOV: FY 2024 revenue up 85% to £19.6m, with strong Reproductive Health and cost efficiencies

January 30, 2025

ALNOV: Revenue up, DHSC dispute resolved, and cost savings position Novacyt for future growth

September 26, 2024